...
首页> 外文期刊>Immunobiology: Zeitschrift fur Immunitatsforschung >A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor
【24h】

A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor

机译:寡关节和多关节青少年特发性关节炎中血清自身抗体靶向的新型基于反应性抗原决定基的抗原和电化学生物传感器的发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Currently, there are no specific markers for juvenile idiopathic arthritis (JIA) diagnosis, which is based on clinical symptoms and some blood tests for diseases' exclusion. Aiming to select new epitope-based antigens (mimotopes) that could recognize circulating autoantibodies in most JIA forms, we screened a phage displayed random peptide library against IgG antibodies purified from serum of JIA patients. ELISA assay was carried out to confirm immunoreactivity of selected peptides against sera IgG antibodies from JIA patients, healthy children and patients with other autoimmune diseases. The mimotope PRE + 1 fused to phage particles was able to efficiently discriminate JIA patients from controls, and for this reason was chosen to be chemically synthesized for validation in a larger sample size. The synthetic peptide was immobilized onto bioelectrodes' surface for antibody detection by electrochemical analyses through differential pulse voltammetry. The PRF + 1 synthetic peptide has efficiently discriminated JIA patients from control groups (p < 0.0001) with a very good accuracy (AUC > 0.84; sensitivity = 61%; specificity = 91%). The electrochemical platform proved to be fast, low cost and effective in detecting anti-PRF + 1 antibodies from JIA patients compared to healthy controls (p = 0.0049). Our study describes a novel and promising epitope-based biomarker for jIA diagnosis that can become a useful tool for screening tests, which was successfully incorporated onto an electrochemical biosensor and could be promptly used in field diagnostics. (C) 2016 Elsevier GmbH. All rights reserved.
机译:目前,尚无用于诊断青少年特发性关节炎(JIA)的特定标志物,该标志物基于临床症状和一些血液检查以排除疾病。为了选择可以识别大多数JIA形式的循环自身抗体的新的基于抗原决定簇的抗原(模拟表位),我们筛选了针对从JIA患者血清中纯化的IgG抗体的噬菌体展示随机肽库。进行ELISA分析以确认所选肽对JIA患者,健康儿童和其他自身免疫性疾病患者的血清IgG抗体的免疫反应性。融合到噬菌体颗粒上的模拟表位PRE + 1能够有效区分JIA患者和对照组,因此选择化学合成以用于更大样本量的验证。通过差分脉冲伏安法通过电化学分析将合成肽固定在生物电极的表面上,以进行抗体检测。 PRF +1合成肽已以非常好的准确性(AUC> 0.84;灵敏度= 61%;特异性= 91%)有效区分了JIA患者和对照组(p <0.0001)。与健康对照相比,电化学平台被证明是快速,低成本且可有效检测JIA患者的抗PRF +1抗体(p = 0.0049)。我们的研究描述了一种新颖且有前途的基于ji诊断的基于表位的生物标记物,该标记物可成为筛选测试的有用工具,已成功地整合到电化学生物传感器中,并可迅速用于现场诊断。 (C)2016 Elsevier GmbH。版权所有。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号